Eric P. Lefkofsky Sells 80,003 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 80,003 shares of the firm’s stock in a transaction on Friday, February 14th. The shares were sold at an average price of $85.78, for a total value of $6,862,657.34. Following the sale, the chief executive officer now directly owns 5,049,460 shares in the company, valued at approximately $433,142,678.80. This trade represents a 1.56 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Tempus AI Stock Up 6.8 %

TEM stock opened at $89.44 on Friday. Tempus AI, Inc. has a 1-year low of $22.89 and a 1-year high of $91.45. The stock has a 50-day moving average price of $46.60 and a 200-day moving average price of $50.32. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.

Analysts Set New Price Targets

Several research analysts have commented on TEM shares. Stifel Nicolaus downgraded Tempus AI from a “buy” rating to a “hold” rating and lifted their target price for the stock from $45.00 to $65.00 in a report on Monday, November 11th. TD Cowen reaffirmed a “buy” rating and set a $74.00 target price (up from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. Guggenheim started coverage on Tempus AI in a report on Monday, December 9th. They set a “buy” rating and a $74.00 target price on the stock. William Blair downgraded Tempus AI from an “outperform” rating to a “market perform” rating in a report on Wednesday. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $56.00 target price on shares of Tempus AI in a report on Tuesday, January 14th. Four investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $58.55.

Institutional Trading of Tempus AI

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. ARK Investment Management LLC increased its position in Tempus AI by 132.1% in the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock valued at $186,343,000 after buying an additional 3,141,487 shares in the last quarter. NEA Management Company LLC increased its position in Tempus AI by 17.8% in the 3rd quarter. NEA Management Company LLC now owns 5,385,979 shares of the company’s stock valued at $304,846,000 after buying an additional 813,169 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. increased its position in Tempus AI by 166.0% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock valued at $109,352,000 after buying an additional 2,021,394 shares in the last quarter. Nikko Asset Management Americas Inc. increased its holdings in Tempus AI by 166.0% during the 4th quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after purchasing an additional 2,021,394 shares in the last quarter. Finally, Franklin Resources Inc. increased its holdings in Tempus AI by 240.5% during the 4th quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company’s stock worth $93,251,000 after purchasing an additional 1,950,862 shares in the last quarter. 24.22% of the stock is owned by institutional investors.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.